CABAZITAXEL (CBZ) plus prednisone (p; cbzp) in patients (pts) with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel (EAP).

Antón Aparicio, Luis Miguel

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/7638

ISSN: 0360-3016

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2012

Journal title

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Type of content

Publicación de congreso